SARS-CoV-2 – Apothera

Put to the test: use of rapid testing technologies for covid-19

By ApoThera June 4, 2022Blog

Put to the test: use of rapid testing technologies for covid-19 BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n208 (Published 03 February 2021)Cite this as: BMJ 2021;372:n208 British Medical Journal

Drug Information for Paxlovid (Nirmatrelvir-Ritonavir), Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application

By ApoThera April 9, 2022Blog

Drug Info: ApoThera Drug Disease Clinical Support App Nirmatrelvir-Ritonavir (Paxlovid) - 300 mg nirmatrelvir + 100 mg Ritonavir by mouth twice daily x 5 days - Initiate as soon as…

Drug Info for Lagevrio (Molnupiravir), Oral Medication for the Treatment of Mild-to-Moderate COVID-19, Available on ApoThera Clinical Decision Support Mobile Application

By ApoThera April 9, 2022Blog

Drug Information for Oral Medications for the Treatment of Mild-to-Moderate COVID-19, Paxlovid (Nirmatrelvir-Ritonavir) and Molnupiravir (Lagevrio), Available on ApoThera Clinical Decision Support Mobile Application Drug Info: ApoThera Drug Disease Clinical…